Background: The incidence of percutaneous lead failure among patients supported with a HeartMate II left ventricular assist device is unknown.
Methods: All HeartMate II left ventricular assist device driveline dysfunctions reported to Thoratec Corporation were retrospectively reviewed. The location and severity of driveline failures and their association with adverse clinical outcomes were examined.